OTC/Supplement Combinations "Serious Concern" For FDA

The appropriateness of combination products containing OTC drug and dietary supplement ingredients is under review at FDA. In the interim, the agency is discouraging firms from marketing such items.

More from Archive

More from Pink Sheet